Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
VABK vs NKSH vs NBTB vs CARE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
VABK vs NKSH vs NBTB vs CARE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $244M | $231M | $2.52B | $662M |
| Revenue (TTM) | $83M | $85M | $902M | $252M |
| Net Income (TTM) | $19M | $16M | $169M | $31M |
| Gross Margin | 69.0% | 65.1% | 73.6% | 61.2% |
| Operating Margin | 28.9% | 22.5% | 24.3% | 15.9% |
| Forward P/E | 12.7x | 11.3x | 11.5x | 5.5x |
| Total Debt | $30M | $2M | $327M | $179M |
| Cash & Equiv. | $6M | $8M | $185M | $105M |
VABK vs NKSH vs NBTB vs CARE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Virginia National B… (VABK) | 100 | 178.2 | +78.2% |
| National Bankshares… (NKSH) | 100 | 127.0 | +27.0% |
| NBT Bancorp Inc. (NBTB) | 100 | 156.6 | +56.6% |
| Carter Bankshares, … (CARE) | 100 | 370.2 | +270.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VABK vs NKSH vs NBTB vs CARE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VABK carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.48, yield 3.1%
- 146.5% 10Y total return vs CARE's 141.7%
- Lower volatility, beta 0.48, Low D/E 16.2%, current ratio 3.53x
- Beta 0.48, yield 3.1%, current ratio 3.53x
NKSH is the clearest fit if your priority is growth exposure.
- Rev growth 7.9%, EPS growth 100.8%
- 4.2% yield, vs NBTB's 3.0%, (1 stock pays no dividend)
NBTB is the #2 pick in this set and the best alternative if valuation efficiency and bank quality is your priority.
- PEG 1.64 vs VABK's 3.36
- NIM 3.1% vs NKSH's 2.5%
- 10.4% NII/revenue growth vs VABK's 0.9%
- Lower P/E (11.5x vs 12.7x), PEG 1.64 vs 3.36
CARE is the clearest fit if your priority is momentum.
- +79.6% vs NBTB's +18.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs VABK's 0.9% | |
| Value | Lower P/E (11.5x vs 12.7x), PEG 1.64 vs 3.36 | |
| Quality / Margins | Efficiency ratio 0.4% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.48 vs NBTB's 0.76, lower leverage | |
| Dividends | 4.2% yield, vs NBTB's 3.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +79.6% vs NBTB's +18.3% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs NBTB's 0.5% |
VABK vs NKSH vs NBTB vs CARE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
VABK vs NKSH vs NBTB vs CARE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VABK leads in 1 of 6 categories
NBTB leads 1 • CARE leads 1 • NKSH leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VABK leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $902M annually — 10.8x VABK's $83M. VABK is the more profitable business, keeping 23.1% of every revenue dollar as net income compared to CARE's 12.5%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $83M | $85M | $902M | $252M |
| EBITDAEarnings before interest/tax | $26M | $20M | $241M | $46M |
| Net IncomeAfter-tax profit | $19M | $16M | $169M | $31M |
| Free Cash FlowCash after capex | $21M | $17M | $225M | $30M |
| Gross MarginGross profit ÷ Revenue | +69.0% | +65.1% | +73.6% | +61.2% |
| Operating MarginEBIT ÷ Revenue | +28.9% | +22.5% | +24.3% | +15.9% |
| Net MarginNet income ÷ Revenue | +23.1% | +18.6% | +18.8% | +12.5% |
| FCF MarginFCF ÷ Revenue | +24.9% | +20.5% | +24.9% | +11.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +31.0% | +91.7% | +39.5% | +8.3% |
Valuation Metrics
NBTB leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.7x trailing earnings, VABK trades at a 41% valuation discount to CARE's 21.3x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 2.06x vs NKSH's 140.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $244M | $231M | $2.5B | $662M |
| Enterprise ValueMkt cap + debt − cash | $268M | $225M | $2.7B | $735M |
| Trailing P/EPrice ÷ TTM EPS | 12.68x | 14.59x | 14.47x | 21.34x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.28x | 11.54x | 5.47x |
| PEG RatioP/E ÷ EPS growth rate | 3.36x | 140.16x | 2.06x | — |
| EV / EBITDAEnterprise value multiple | 11.13x | 11.74x | 11.03x | 18.38x |
| Price / SalesMarket cap ÷ Revenue | 2.93x | 2.71x | 2.90x | 2.60x |
| Price / BookPrice ÷ Book value/share | 1.32x | 1.25x | 1.29x | 1.60x |
| Price / FCFMarket cap ÷ FCF | 11.76x | 15.27x | 11.49x | 20.81x |
Profitability & Efficiency
Evenly matched — VABK and NKSH each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
VABK delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $8 for CARE. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), NKSH scores 8/9 vs VABK's 6/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.0% | +9.0% | +9.5% | +7.6% |
| ROA (TTM)Return on assets | +1.2% | +0.9% | +1.1% | +0.7% |
| ROICReturn on invested capital | +9.0% | +8.4% | +7.9% | +5.7% |
| ROCEReturn on capital employed | +2.6% | +1.9% | +2.4% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.16x | 0.01x | 0.17x | 0.43x |
| Net DebtTotal debt minus cash | $24M | -$6M | $142M | $73M |
| Cash & Equiv.Liquid assets | $6M | $8M | $185M | $105M |
| Total DebtShort + long-term debt | $30M | $2M | $327M | $179M |
| Interest CoverageEBIT ÷ Interest expense | 0.94x | 0.64x | 1.05x | 0.39x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $20,802 today (with dividends reinvested), compared to $12,431 for NKSH. Over the past 12 months, CARE leads with a +79.6% total return vs NBTB's +18.3%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.7% vs NKSH's 11.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.2% | +12.3% | +17.6% | +54.3% |
| 1-Year ReturnPast 12 months | +24.1% | +42.4% | +18.3% | +79.6% |
| 3-Year ReturnCumulative with dividends | +61.9% | +37.2% | +48.5% | +93.9% |
| 5-Year ReturnCumulative with dividends | +50.9% | +24.3% | +44.4% | +108.0% |
| 10-Year ReturnCumulative with dividends | +146.5% | +54.9% | +108.5% | +141.7% |
| CAGR (3Y)Annualised 3-year return | +17.4% | +11.1% | +14.1% | +24.7% |
Risk & Volatility
Evenly matched — VABK and NBTB each lead in 1 of 2 comparable metrics.
Risk & Volatility
VABK is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than NBTB's 0.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NBTB currently trades 99.8% from its 52-week high vs NKSH's 90.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.73x | 0.76x | 0.58x |
| 52-Week HighHighest price in past year | $48.58 | $40.00 | $48.27 | $29.99 |
| 52-Week LowLowest price in past year | $36.48 | $24.74 | $39.20 | $16.14 |
| % of 52W HighCurrent price vs 52-week peak | +92.6% | +90.8% | +99.8% | +99.6% |
| RSI (14)Momentum oscillator 0–100 | 63.0 | 55.1 | 63.1 | 72.8 |
| Avg Volume (50D)Average daily shares traded | 6K | 49K | 266K | 316K |
Analyst Outlook
Evenly matched — NKSH and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NKSH as "Buy", NBTB as "Hold", CARE as "Hold". Consensus price targets imply -4.5% upside for NBTB (target: $46) vs -4.6% for CARE (target: $29). For income investors, NKSH offers the higher dividend yield at 4.16% vs NBTB's 2.96%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | — | $46.00 | $28.50 |
| # AnalystsCovering analysts | — | 4 | 10 | 5 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +4.2% | +3.0% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | 13 | 0 |
| Dividend / ShareAnnual DPS | $1.40 | $1.51 | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.4% | +3.0% |
VABK leads in 1 of 6 categories (Income & Cash Flow). NBTB leads in 1 (Valuation Metrics). 3 tied.
VABK vs NKSH vs NBTB vs CARE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VABK or NKSH or NBTB or CARE a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus 0. 9% for Virginia National Bankshares Corporation (VABK). Virginia National Bankshares Corporation (VABK) offers the better valuation at 12. 7x trailing P/E, making it the more compelling value choice. Analysts rate National Bankshares, Inc. (NKSH) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VABK or NKSH or NBTB or CARE?
On trailing P/E, Virginia National Bankshares Corporation (VABK) is the cheapest at 12.
7x versus Carter Bankshares, Inc. at 21. 3x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NBT Bancorp Inc. wins at 1. 64x versus National Bankshares, Inc. 's 140. 16x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — VABK or NKSH or NBTB or CARE?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +108. 0%, compared to +24. 3% for National Bankshares, Inc. (NKSH). Over 10 years, the gap is even starker: VABK returned +146. 5% versus NKSH's +54. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VABK or NKSH or NBTB or CARE?
By beta (market sensitivity over 5 years), Virginia National Bankshares Corporation (VABK) is the lower-risk stock at 0.
48β versus NBT Bancorp Inc. 's 0. 76β — meaning NBTB is approximately 59% more volatile than VABK relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VABK or NKSH or NBTB or CARE?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus 0. 9% for Virginia National Bankshares Corporation (VABK). On earnings-per-share growth, the picture is similar: National Bankshares, Inc. grew EPS 100. 8% year-over-year, compared to 12. 5% for NBT Bancorp Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VABK or NKSH or NBTB or CARE?
Virginia National Bankshares Corporation (VABK) is the more profitable company, earning 23.
1% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 23. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VABK leads at 28. 9% versus 15. 7% for CARE. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VABK or NKSH or NBTB or CARE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NBT Bancorp Inc. (NBTB) is the more undervalued stock at a PEG of 1. 64x versus National Bankshares, Inc. 's 140. 16x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 5. 5x forward P/E versus 11. 5x for NBT Bancorp Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NBTB: -4. 5% to $46. 00.
08Which pays a better dividend — VABK or NKSH or NBTB or CARE?
In this comparison, NKSH (4.
2% yield), VABK (3. 1% yield), NBTB (3. 0% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is VABK or NKSH or NBTB or CARE better for a retirement portfolio?
For long-horizon retirement investors, Virginia National Bankshares Corporation (VABK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
48), 3. 1% yield, +146. 5% 10Y return). Both have compounded well over 10 years (VABK: +146. 5%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VABK and NKSH and NBTB and CARE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VABK is a small-cap deep-value stock; NKSH is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock. VABK, NKSH, NBTB pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.